Mucin-type O-glycans in human colon and breast cancer: Glycodynamics and functions

EMBO Reports

Volumn 7, Issue 6, 2006, Pages 599-604

  Brockhausen, Inka ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Breast cancer cell; Colon cancer cell; Glycoprotein; Glycosyltransferase; O glycosylation

Indexed keywords

CANCER VACCINE; GLYCAN; GLYCOPROTEIN; GLYCOSYLTRANSFERASE; INTEGRIN; MUCIN; TN ANTIGEN; UVOMORULIN; VIRUS T ANTIGEN;

BLOOD GROUP LEWIS SYSTEM; BREAST CANCER; CANCER CELL; CANCER DIAGNOSIS; CARBOHYDRATE ANALYSIS; CELL ADHESION; CELL FUNCTION; CELL INVASION; COLON CANCER; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME GLYCOSYLATION; ENZYME LOCALIZATION; GOLGI COMPLEX; HUMAN; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW;

BREAST NEOPLASMS; COLONIC NEOPLASMS; FEMALE; GLYCOSYLATION; GLYCOSYLTRANSFERASES; HUMANS; MUCINS; POLYSACCHARIDES;

EID: 33744799438     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/sj.embor.7400705     Document Type: Review

References (58)

1. Berois N, Mazal D, Ubillos L, Trajtenberg F, Nicolas A, Sastre-Garau X, Magdalenat H, Osinaga E (2006) UDP-N-acetylgalactosamine: Polypeptide N-acetylgalactosaminyltransferase-6 as a new immunohistochemical breast cancer marker. J Histochem Cytochem 54: 317-328
2. Blottiere HM, Burg C, Zennadi R, Perrin P, Blanchardie P, Bara J, Meflah K, LePendu J (1992) Involvement of histo-blood-group antigens in the susceptibility of colon carcinoma cells to natural killer-mediated cytotoxicity. Int J Cancer 52: 609-618
3. Bresalier R, Ho S, Schoeppner H, Kim Y, Sleisenger M, Brodt P, Byrd J (1996) Enhanced sialyation of mucin-associated carbohydrate structures in human colon cancer metastasis. Gastroenterology 110: 1354-1367
4. Brockhausen I (1999) Pathways of O-glycan biosynthesis in cancer cells. Biochim Biophys Acta 1473: 67-95
5. Brockhausen I (2003a) Sulfotransferases involved in glycoprotein synthesis. Biochem Soc Trans 31: 318-325
6. Brockhausen I (2003b) Glycodynamics of mucin biosynthesis in gastrointestinal tumour cells. Adv Exp Med Biol 535: 163-188
7. Brockhausen I, Kuhns W (1997) Glycoproteins and Human Disease. Medical Intelligence Unit, CRC Press and Mosby Year Book. New York, USA: Chapman & Hall
8. Brockhausen I, Möller G, Merz G, Adermann K, Paulsen H (1990) Control of glycoprotein synthesis: The peptide portion of synthetic O-glycopeptide substrates influences the activity of O-glycan core 1 uridine 5′-diphospho-galactose: N-acetylgalactosaminea-R β3-galactosyl-transferase. Biochemistry 29: 10206-10212
9. Brockhausen I, Yang J, Burchell J, Whitehouse C, Taylor-Papadimitriou J (1995) Mechanism underlying aberrant glycosylation of the MUC1 mucin in breast cancer cells. Eur J Biochem 233: 607-617
10. Brockhausen I, Yang J, Dickinson N, Ogata S, Itzkowitz S (1998a) Enzymatic basis for sialyl-Tn expression in human colon cancer cells. Glycoconj J 15: 595-603
11. Brockhausen I, Schutzbach J, Kuhns W (1998b) Glycoproteins and their relationship to human disease. Acta Anat 161: 36-78
12. Brockhausen I, Yang J, Lehotay M, Ogata S, Itzkowitz S (2001) Pathways of mucin O-glycosylation in normal and malignant rat colonic epithelial cells reveal a mechanism for cancer-associated sialyl-Tn antigen expression. Biol Chem 382: 219-232
13. Brockhausen I, Benn M, Bhat S, Marone S, Riley JG, Montoya-Peleaz P, Vlahakis JZ, Paulsen H, Schutzbach JS, Szarek W (2006) UDP-Gal: GlcNAc-R β1,4-galactosyltransferase - a target enzyme for drug design. Acceptor specificity and inhibition of the enzyme. Glycoconj J 23 (in the press)
14. Burchell J, Poulsom R, Hanby A, Whitehouse C, Cooper L, Clausen H, Miles D, Taylor-Papadimitriou J (1999) An α2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas. Glycobiology 9: 1307-1311
15. Burchell J, Mungul A, Taylor-Papadimitriou J (2001) O-linked glycosylation in the mammary gland: Changes that occur during malignancy. Mammary Gland Biol Neoplasia 6: 355-364
16. Crocker PR (2005) Siglecs in innate immunity. Curr Opin Pharmacol 5: 431-437
17. David L, Leitao D, Sobrinho-Simoes M, Bennett EP, White T, Mandel U, Dabelsteen E, Clausen H (1993) Biosynthetic basis of incompatible histoblood group A antigen expression: Anti-A transferase antibodies reactive with gastric cancer tissue of type O individuals. Cancer Res 53: 5494-5500
18. Delmotte P, Degroote S, Lafitte JJ, Lamblin G, Perini JM, Roussel P (2002) Tumor necrosis factor alpha increases the expression of glycosyltransferases and sulfotransferases responsible for the biosynthesis of sialylated and/or sulfated Lewis x epitopes in the human bronchial mucosa. J Biol Chem 277: 424-431
19. Egea G, Francí C, Gambús G, Lesuffleur T, Zweibaum A, Real FX (1993) cis-Golgi resident proteins and O-glycans are abnormally compartmentalized in the RER of colon cancer cells. J Cell Sci 105: 819-830
20. Fung PYS, Madej M, Koganty RR, Longenecker BM (1990) Active specific immunotherapy of a murine mammary adenocarcinoma using a synthetic tumor-associated glycoconjugate. Cancer Res 50: 4308-4314
21. Gerloni M, Castiglioni P, Zanetti M (2005) The cooperation between two CD4T cells induces tumor protective immunity in MUC.1 transgenic mice. J Immunol 175: 6551-6559
22. Hanski C, Klußmann E, Wang J, Böhm C, Ogorek D, Hanski ML, Krüger-Krasagakes S, Eberle J, Schmitt-Gräff A, Riecken EO (1996) Fucosyltransferase III and sialyl-Le(x) expression correlate in cultured colon carcinoma cells but not in colon carcinoma tissue. Glycoconj J 13: 727-733
23. Hollingsworth MA, Swanson BJ (2004) Mucins in cancer: Protection and control of the cell surface. Nat Rev Cancer 4: 45-60
24. Ito H, Hiraiwa N, Sawada-Kasugai M, Akamatsu S, Tachikawa T, Kasai Y, Akiyama S, Ito K, Takagi H, Kannagi R (1997) Altered mRNA expression of specific molecular species of fucosyl- and sialyl-transferases in human colorectal cancer tissues. Int J Cancer 71: 556-564
25. Itzkowitz SH, Bloom EJ, Kokal WA, Modin G, Hakomori SI, Kim YS (1990) Sialosyl-Tn: A novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer 66: 1960-1966
26. Jass JR, Walsh MD (2001) Altered mucin expression in the gastrointestinal tract: A review. J Cell Mol Med 5: 327-351
27. Julien S, Lagadec C, Krzewinski-Recchi M, Courtand G, Le Bourhis X, Delannoy P (2005) Stable expression of sialyl-Tn antigen in T47-D cells induces a decrease of cell adhesion and an increase of cell migration. Breast Cancer Res Treat 90: 77-84
28. Kojima N, Handa K, Newman W, Hakomori S (1992) Inhibition of selectin-dependent tumor cell adhesion to endothelial cells and platelets by blocking O-glycosylation of these cells. Biochem Biophys Res Commun 182: 1288-1295
29. Kudo T, Ikehara Y, Togayachi A, Morozumi K, Watanabe M, Nakamura M, Nishihara S, Narimatsu H (1998) Up-regulation of a set of glycosyltransferase genes in human colorectal cancer. Lab Investig 78: 797-811
30. Lowe JB (2003) Glycan-dependent leukocyte adhesion and recruitment in inflammation. Curr Opin Cell Biol 15: 531-538
31. Magnani JL, Steplewski Z, Koprowski H, Ginsburg V (1983) Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. Cancer Res 43: 5489-5492
32. Mandel U, Hassan H, Therkildsen MH, Rygaard J, Jakobsen MH, Juhl BR, Dabelsteen E, Clausen H (1999) Expression of polypeptide GalNAc-transferases in stratified epithelia and squamous cell carcinomas: Immunohistological evaluation using monoclonal antibodies to three members of the GalNAc-transferase family. Glycobiology 9: 43-52
33. x, the carbohydrate ligands for E-selectin, in human breast cancer. Int J Oncol 12: 1157-1164
34. Mungul A, Cooper L, Brockhausen I, Ryder K, Mandel U, Clausen H, Rughetti A, Miles DW, Taylor-Papadimitriou J, Burchell JM (2004) Sialylated core 1 based O-linked glycans enhance the growth rate of mammary carcinoma cells in MUC1 transgenic mice. Int J Oncol 25: 937-943
35. x antigen correlates with poor survival in patients with colorectal carcinoma: Clinicopathological and immunohistochemical study. Cancer Res 53: 3632-3637
36. x expression level in human Pre-B lymphocytic leukemia cell line KM3 treated with phorbolester. J Biol Chem 273: 26779-26789
37. Nishihara S, Hiraga T, Ikehara Y, Kudo T, Iwasaki H, Morozumi K, Akamatsu S, Tachikawa T (1999) Molecular mechanisms of expression of Lewis β antigen and other type I Lewis antigens in human colorectal cancer. Glycobiology 9: 607-616
38. Ogata S, Maimonis PJ, Itzkowitz SH (1992) Mucins bearing the cancer-associated sialosyl-Tn antigen mediate inhibition of natural killer cell cytotoxicity. Cancer Res 52: 4741-4746
39. Ogata S, Koganty R, Reddish M, Longenecker BM, Chen A, Perez C, Itzkowitz SH (1998) Different modes of sialyl-Tn expression during malignant transformation of human colonic mucosa. Glycoconj J 15: 29-35
40. Onami TM, Harrington LE, Williams MA, Galvan M, Larsen CP, Pearson TC, Manjunath N, Baum LG, Pearce BD, Ahmed R (2002) Dynamic regulation of T cell immunity by CD43. J Immunol 168: 6022-6031
41. Petretti T, Kemmner W, Schulze B, Schlag PM (2000) Altered mRNA expression of glycosyltransferases in human colorectal carcinomas and liver metastases. Gut 46: 359-366
42. Roth J, Wang Y, Eckhardt AE, Hill RL (1994) Subcellular localization of the UDP-N-acetyl-D-galactosamine: Polypeptide N-acetylgalactosaminyltransferase-mediated O-glycosylation reaction in the submaxillary gland. Proc Natl Acad Sci USA 91: 8935-8939
43. Röttger S, White J, Wandall HH, Olivo JC, Stark A, Bennett EP, Whitehouse C, Berger EG, Clausen H, Nilsson T (1998) Localization of three human polypeptide GalNAc-transferases in HeLa cells suggests initiation of O-linked glycosylation throughout the Golgi apparatus. J Cell Sci 111: 45-60
44. Schneider F, Kemmer W, Haensch W, Franke G, Gretschel S, Karsten U, Schlag PM (2001) Overexpression of sialyltransferase CMP-sialic acid: Galβ1, 3GalNAc-R α6-sialyltransferase is related to poor patient survival in human colorectal carcinomas. Cancer Res 61: 4605-4611
45. Schwientek T, Nomoto M, Levery SB, Merkx G, van Kessel AG, Bennett EP, Hollingsworth MA, Clausen H (1999) Control of O-glycan branch formation. Molecular cloning of human cDNA encoding a novel β1,6-N-acetylglucosaminyltransferase forming core 2 and core 4. J Biol Chem 274: 4504-4512
46. Sewell R et al (2006) The ST6GalNAc-I sialyltransferase localises throughout the Golgi and is responsible for the synthesis of the tumour-associated sialyl Tn O-glycan in human breast cancer. J Biol Chem 281: 3586-3594
47. Shibao K et al (2002) Expression of UDP-N-acetyl-α-D-galactosamine-polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in relation to differentiation and prognosis in patients with colorectal carcinoma. Cancer 94: 1939-1946
48. Shimodaira K, Nakayama J, Nakamura N, Hasebe O, Katsuyama T, Fukuda M (1997) Carcinoma-associated expression of core 2 β-1,6-N-acetylglucosaminyltransferase gene in human colorectal cancer: role of O-glycans in tumor progression. Cancer Res 57: 5201-5206
49. Singhal A, Fohn M, Hakomori S (1991) Induction of α-N-acetylgalactosamine-O-serine (Tn) antigen-mediated cellular immune response for active immunotherapy in mice. Cancer Res 51: 1406-1411
50. Springer GF, Desai PR, Spencer BD, Tegtmeyer H, Carlstedt SC, Scanlon EF (1995) T/Tn antigen vaccine is effective and safe in preventing recurrence of advanced breast carcinoma. Cancer Detect Prev 19: 374-380
51. Stepensky D, Tzehoval E, Vadai E, Eisenbach L (2006) O-glycosylated versus non-glycosylated MUC1-derived peptides as potential targets for cytotoxic immunotherapy of carcinoma. Clin Exp Immunol 143: 139-149
52. Ten Hagen KG, Fritz TA, Tabak LA (2003) All in the family: The UDP-GalNAc: Polypeptide N-acetylgalactosaminyltransferases. Glycobiology 13: 1R-16R
53. Tsuji H, Takasaki S, Sakamoto M, Irimura T, Hirohashi S (2003) Aberrant O-glycosylation inhibits stable expression of dysadherin, a carcinoma-associated antigen, and facilitates cell-cell adhesion. Glycobiology 13: 521-527
54. van de Wiel-van Kemenade E, Ligtenberg MJ, de Boer AJ, Buijs F, Vos HL, Melief CJ, Hilkens J, Figdor CG (1993) Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction. J Immunol 151: 767-776
55. Varki A, Angata T (2006) Siglecs - the major sub-family of I-type lectins. Glycobiology 16: 1R-27R
56. Vavasseur F, Dole K, Yang J, Matta K, Myerscough N, Corfield A, Paraskeva C, Brockhausen I (1994) O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer. Eur J Biochem 222: 415-424
57. Vavasseur F, Yang J, Dole K, Paulsen H, Brockhausen I (1995) Synthesis of core 3: Characterization of UDP-GlcNAc: GalNAc β3-N-acetylglucosaminyltransferase activity from colonic tissues. Loss of the activity in human cancer cell lines. Glycobiology 5: 351-357
58. Yang X, Lehotay M, Anastassiades T, Harrison M, Brockhausen I (2004) The effect of TNF-α on glycosylation pathways in bovine synoviocytes. Biochem Cell Biol 82: 559-568